Interventional cardiology in a whole new light

Open menu

News & Events

OPSENS TO PRESENT AT THE LD MICRO INVITATIONAL

22 May 2019

Quebec City, Quebec, May 22, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a company focusing mainly on physiological measurements such as Fractional Flow Reserve (“FFR”) and Diastolic Pressure Ratio (“dPR”) in interventional cardiology, will present at the LD Micro 9th Invitational investor conference on Tuesday, June 4, 2019 at 8:40 am PST. Louis Laflamme, Opsens’…

Read more

Visit Opsens at C3 2019

10 May 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at the C3 2019 Conference by attending Opsens’ complimentary lunch  and educational symposium.  The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with confidence. Opsens second…

Read more

Visit Opsens at EuroPCR 2019

10 May 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at EuroPCR 2019 by attending Opsens’ complimentary Case-In-Point session or visit Opsens at the exhibition: Booth #64, level 2. The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with…

Read more